Expert-led, practical training designed for AML officers, legal advisors, and senior leaders across multiple industries Open to professionals worldwide, the self-paced course is tailored to a broad ...

Over the course of treatment, patients with relapsed/refractory acute myeloid leukemia (AML) may acquire new TP53 mutations, making ongoing monitoring for mutations crucial. “New novel therapies ...